ClinicalTrials.Veeva

Menu

Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration. (PUP-AIT)

A

Antwerp University Hospital (UZA)

Status

Completed

Conditions

Pain, Acute
Anesthesia

Treatments

Other: Standard of care
Diagnostic Test: Pupillary dilation reflex

Study type

Interventional

Funder types

Other

Identifiers

NCT03248908
17/28/319

Details and patient eligibility

About

In this double blinded randomized controlled study, the pupillary dilation reflex is used for as a nociceptive indicator for opioid administration during elective surgery under general anesthesia.

Full description

An infrared camera of the video pupillometer measures the pupillary dilation reflex (PDR) in response of a nociceptive stimulus. This autonomic reflex, parasympathetic mediated in sedated patients, can be generated by various pain stimuli (built in standardized protocol, surgical incision, ...) The PDR is a robust reflex, even in patients under general anesthesia, and provides a potential evaluation of the autonomous circuit within the nociceptive evaluation based on pupil dilation upon A-delta and C fibers in both electrical or mechanic stimulation. This double blind randomized controlled trial involving American Society of Anesthesiologists (ASA) classification I-III patients undergoing elective surgery under general anesthesia are recruited. Enrolled patients are randomized in four groups: (1) remifentanil administration depending on PDR results, (2) remifentanil administration depending on decision attending anesthesiologist, (3) sufentanil administration depending on PDR results, (4) sufentanil administration depending on decision attending anesthesiologist.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 jaar
  • Elective abdominal or gynaecological operation
  • ASA (American Society of Anesthesiologists classification): I - II - III

Exclusion criteria

  • History of invasive ophthalmological surgery
  • Known bilateral eye disease
  • Known optical of oculomotor nerve deficit
  • Active psychiatrical disease
  • Proven active pheochromocytoma
  • Opioid usage > 7 days preoperative
  • Ongoing oncological treatment with chemotherapeutic agents
  • Usage of A-1 adrenergic of beta-blocking agents
  • Preoperative usage of benzodiazepines
  • Topical atropine or phenylephrine (eye droplets)
  • Planned perioperative usage of dopamine antagonists

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

120 participants in 4 patient groups

Intervention 1
Experimental group
Description:
Pupillary dilation reflex based perioperative intravenous remifentanil administration. Starting dose 5 ng/ml by continous infusion, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, the dosage is decreased with 0.2 ng/ml. When PPI score is greater than 1, the dosage is increased with 0.2 ng/ml.
Treatment:
Diagnostic Test: Pupillary dilation reflex
Intervention 2
Active Comparator group
Description:
Anesthesiologist based perioperative intravenous remifentanil administration (daily practice, standard of care). Starting dose 5 ng/ml, dosage adjustments are made when deemed necessary by attending anesthesiologist.
Treatment:
Other: Standard of care
Intervention 3
Experimental group
Description:
Pupillary dilation reflex based perioperative intravenous sufentanil administration. Starting dose 0.1 mcg/kg bolus, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, no supplementary administration is executed. When PPI score is greater than 1, a supplementary bolus of 0.1 mcg/kg is given.
Treatment:
Diagnostic Test: Pupillary dilation reflex
Intervention 4
Active Comparator group
Description:
Anesthesiologist based perioperative intravenous sufentanil administration (daily practice, standard of care). Starting dose 0.1 mcg/kg bolus, dosage adjustments are made when deemed necessary by attending anesthesiologist.
Treatment:
Other: Standard of care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems